Oral ribavirin for treatment of respiratory syncitial virus and parainfluenza 3 virus infections post allogeneic haematopoietic stem cell transplantation

The characteristics and outcomes of parainfluenza virus infections in 200 patients with leukemia or recipients of hematopoietic stem cell transplantation

(2012) R. F. Chemaly et al.   BLOOD

Oral versus inhaled ribavirin therapy for respiratory syncytial virus infection after lung transplantation

(2012) Lily Li et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

A parainfluenza-3 outbreak in a SCT unit: sepsis with multi-organ failure and multiple co-pathogens are associated with increased mortality

(2011) A Hodson et al.   BONE MARROW TRANSPLANTATION

Clinical and radiological features of respiratory syncytial virus in solid organ transplant recipients: a single-center experience

(2011) E.J. Ariza-Heredia et al.   Transplant Infectious Disease

Management of RSV infections in adult recipients of hematopoietic stem cell transplantation

(2010) J. N. Shah et al.   BLOOD

Control of an Outbreak of Human Parainfluenza Virus 3 in Hematopoietic Stem Cell Transplant Recipients

(2009) Richard T. Maziarz et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Efficacy of Oral Ribavirin in Lung Transplant Patients With Respiratory Syncytial Virus Lower Respiratory Tract Infection

(2009) Andres Pelaez et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Respiratory Syncytial Virus Infection in Recipients of Allogeneic Stem-Cell Transplantation: A Retrospective Study of the Incidence, Clinical Features, and Outcome

(2009) Gayane Avetisyan et al.   TRANSPLANTATION

Comparing Nose-Throat Swabs and Nasopharyngeal Aspirates Collected From Children With Symptoms for Respiratory Virus Identification Using Real-Time Polymerase Chain Reaction

(2008) S. B. Lambert et al.   PEDIATRICS

Respiratory Syncytial Virus Infection in Patients with Hematological Diseases: Single-Center Study and Review of the Literature

(2007) N. Khanna et al.   CLINICAL INFECTIOUS DISEASES